CTSB and COVID-19: Among them, glycyrrhizin and glycyrrhetinic acid interact with ACE 2, spike protein, host transmembrane serine protease 2 and 3-chymotrypsin-like cysteine protease to alleviate the common symptoms of COVID-19 patients, such as pulmonary inflammation and liver and kidney injury.